2011 · Paper V · 10 marksFrequently asked

What do you understand by a vaccine? Describe the journey of development from conventional to modern day (Recombinant vaccines).

In short

A vaccine is a biological preparation that builds adaptive immunity by exposing the body to a weakened, killed or partial pathogen or its genetic material. Development moved from Jenner's smallpox vaccine (1796) and whole-pathogen vaccines to recombinant sub-unit vaccines like hepatitis B, and now to DNA and mRNA platforms.

Model answer

Ghissu Editorial · Verified 4 Oct 2026

Introduction
Vaccines have evolved from conventional whole-pathogen types to advanced recombinant platforms, improving immunisation speed and safety. India’s Universal Immunisation Programme highlights expanded coverage amid emerging health challenges. This evolution reflects scientific advances enabling more precise and adaptable vaccine designs.
Institutional Framework and Capacity
•

India’s Manufacturing Strength

Serum Institute and Bharat Biotech are global leaders, supported by government initiatives like the COVID Suraksha Mission to boost indigenous vaccine R&D. Their capacity enabled rapid COVID-191 vaccine development and mass production, showcasing India’s growing vaccine ecosystem.

Implementation Challenges and Outcomes
•

Clinical Trials and Hesitancy

Vaccine development requires phased trials; India adopted emergency use authorisation during COVID-19. Despite expanded coverage, hesitancy remains, especially for HPV vaccines. India’s nationwide HPV vaccination drive2 targets 11.5 million girls to reduce cervical cancer and address social resistance. Public education and community engagement are critical to overcoming these barriers.

•

Surveillance and Future Directions

Continuous variant monitoring is vital; integration challenges exist. Strengthening surveillance, boosting R&D investment, and expanding public awareness, especially in Andhra Pradesh’s rural districts, are key to improving vaccine uptake. Initiatives like the One Health Mission aim to integrate human and animal disease surveillance for early threat detection.

Conclusion
The shift to recombinant vaccines and strengthened indigenous capacity, combined with targeted campaigns like HPV vaccination, are crucial for India’s health security and Universal Immunisation Programme success. These efforts align with global health goals, ensuring equitable and effective immunisation coverage.

This model answer is indicative and the model can make mistakes; please verify key facts independently.

Hand-drawn diagram: Conventional vs recombinant vaccines. Conventional vs recombinant vaccines. Comparison of Conventional and Recombinant
Diagram: Conventional vs recombinant vaccines

Practise this question

  1. 1Get the answer sheet

    Sized for this question.

  2. 2Write your answer

    Timed, by hand.

  3. 3Get it marked

    Your score and what to fix.

Share this questionWhatsAppTelegramXLinkedIn

This chapter in the exam

Human diseases; genetic engineering basics; biotechnology in agriculture; vaccines54 questions

Asked in 8 of 8 sittings since 2008

2008
5
2011
6
2012
15
2016
11
2017
4
2020
5
2023
3
2025
5

Most tested: Vaccines and immunisation, alongside GM crops/biotech agriculture.

All 54 questions, sorted by sub-topic, with model answers and practice.

Question from the official APPSC Group-I Mains 2011 paper. Answer written by Ghissu's engine and checked against our editorial standards. Found an error? Tell us and we correct it within 48 hours.

Ghissu

OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·